Medical Devices & Tech

NeuroMetrix

62 Fourth Ave.
Waltham, MA 02451 USA
Phone
Fax
Click for website

Research Sector Medical Devices & Tech

Summary Description Diagnosis and treatment of neurological complications of diabetes.

Management Shai N. Gozani, M.D., Ph.D., President, Chief Executive Officer and Director; Thomas T. Higgins, Senior Vice President and Chief Financial Officer; Guy Daniello, Senior Vice President of Information Technology; Michael Williams, Ph.D., Senior Vice President and Chief Technology Officer; Michael J. MacDonald, Senior Vice President of Commercial Operations; Xuan Kong, Ph.D., Senior Vice President of Research and Intellectual Property Board of Director's Shai N. Gozani, M.D. Ph.D. Chairman of the Board, President and Chief Executive Officer Allen Hinkle, M.D. Director David E. Goodman, M.D. Director Timothy R. Surgenor Director Nancy E. Katz Director David Van Avermaete Director

Click here for Financial Data
Keywords: diabetes, diagnostics, diabetes diagnostics, pain management, diabetic peripheral neuropathy, SENSUS, NC-stat DPNCheck

Comment


Updated: May 22, 2017


Description

NeuroMetrix is a publicly traded medical device company located in Waltham, Massachusetts. NeuroMetrix develops and markets home use and point-of-care devices for the treatment and management of chron......view more

Products / Services

NeuroMetrix markets the SENSUS Pain Management System for treating chronic pain, focusing on physicians managing patients with painful diabetic neuropathy. The company also markets the DPNCheck device......view more

Technology / Differentiation

NeuroMetrix develops and markets home use and point-of-care devices for treatment and management of diabetic neuropathy. **Diabetic Neuropathy: A family of nerve disorders caused as a result of di...view more

Market / Customers

Products are marketed domestically and outside the US to managed care organizations, primary care physicians, endocrinologists, and retail health professionals. NeuroMetrix created the market for poin......view more


Competitors / Substitutes / Alternatives

Proprietary technology. No direct competition in diabetic peripheral neuropathy products (diagnostics and therapeutics) Competition in the general nerve testing product arena from Natus, Cadwell, Car...view more

Strategy

Drive commercial adoption of NC-stat DPNCheck in US and international markets. Expand products to include SENSUS, a pain therapy device. Initiate clinical studies to further validate clinical and eco...view more

Revenue / Funding

2011 Revenue = $10M. Cash resources = $10M at Q3 2012...view more

Status

Products are FDA approved and in the market...view more

Analyst Coverage